HRCVX
Price
$21.12
Change
+$0.16 (+0.76%)
Updated
Sep 11 closing price
Net Assets
488.31M
RMEBX
Price
$63.87
Change
+$0.34 (+0.54%)
Updated
Sep 11 closing price
Net Assets
117.47B
Interact to see
Advertisement

HRCVX vs RMEBX

HRCVX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
HRCVX vs. RMEBX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRCVX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 117B vs. HRCVX (488M). RMEBX (0.99) and HRCVX (0.98) have matching dividends . HRCVX was incepted earlier than RMEBX: HRCVX (40 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than HRCVX (0.97). HRCVX is a more actively managed with annual turnover of: 47.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than HRCVX: RMEBX (250) vs HRCVX (1000). RMEBX annual gain was more profitable for investors over the last year : 4.65 vs. HRCVX (-6.31). RMEBX return over 5 years is better than : 34.68 vs. HRCVX (-12.69).
HRCVXRMEBXHRCVX / RMEBX
Total Expense Ratio0.971.0791%
Annual Report Gross Expense Ratio0.971.0791%
Fund Existence40 years12 years-
Gain YTD10.1008.448120%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets488M117B0%
Annual Yield % from dividends0.980.9999%
Returns for 1 year-6.314.65-136%
Returns for 3 years1.3834.884%
Returns for 5 years-12.6934.68-37%
Returns for 10 years28.6192.4531%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INGN5.310.13
+2.51%
Inogen
XWEL0.950.01
+1.06%
XWELL
MDLN32.530.14
+0.43%
Medline Inc
CGBD11.37-0.01
-0.09%
Carlyle Secured Lending
PLSE53.11-1.32
-2.43%
Pulse Biosciences